Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: Current standards of care

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 53, Issue 3, 2013, Pages 231-235

  Giles, Michelle L ^a   Grace, Ruth ^b   Tai, Amy ^c   Michalak, Katarzyna ^b   Walker, Susan P ^d  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b NORTHERN HOSPITAL   (Australia)

^c BARWON HEALTH   (Australia)

^d Mercy Health Victoria   (Australia)

Author keywords

guidelines; hepatitis B; pregnancy; puerperium

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MOTHER TO CHILD TRANSMISSION; MULTICENTER STUDY; NEWBORN HEPATITIS; NONHUMAN; PATIENT REFERRAL; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUERPERIUM; RETROSPECTIVE STUDY; VACCINATION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; VICTORIA; VIRAL LOAD; VIRUS REPLICATION; YOUNG ADULT;

EID: 84878551830     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12061     Document Type: Article

References (12)

1. Buchanan C, Tran T,. Management of Chronic Hepatitis B in pregnancy. Clin Liver Dis 2010; 14 (3): 495-504.
2. Wiseman E, Fraser MA, Holden S, et al,. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190: 489-492.
3. RANZCOG. Royal Australian and New Zealand College of Obstetricians and Gynaecologists College Statement Hepatitis B (C-Gen 3), 2009. [Accessed 21 March 2011.] Available from http://www.ranzcog.edu.au/the-ranzcog/policies-and- guidelines/college-statements.html
4. Dore G, Wallace J, Locarnini S, et al,. Hepatitis B in Australia: Responding to a Diverse Epidemic. [Accessed 21 March 2011.]Available from http://alliance.hepatitis.org.au/uploads/ACT-HBV.pdf
5. Burk RD, Hwang LY, Ho GY, et al,. Outcome of perinatal hepatitis B virus exposure is dependent on maternal viral load. J Infect Dis 1994; 170: 1418-1423.
6. Xu W, Cui Y, Wang L, et al,. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre randomised, double blind, placebo controlled study. J Viral Hepat 2009; 16: 94-103.
7. Lei H, Hong-Wei Z, Jia-Xin X, et al,. A meta-analysis of lamivuidne for interruption of mother to child transmission of hepatitis B virus. World J Gastroenterol 2011; 17 (38): 4321-4333.
8. Davies G, Wilson RD, Desilets V, et al,. Amniocentesis and women with hepatitis B, hepatitis C or human immunodeficiency virus. J Obstet Gynaecol Can 2003; 25 (2): 145-152.
9. Lopez M, Coll O,. Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther 2010; 28 (1): 1-8.
10. Alfirevic Z, Walkinshaw SA, Kilby MD,. Amniocentesis and chorionic villous sampling. Green Top 8, 2010. [Accessed 21 March 2011.] Available from http://www.rcog.org.uk/files/rcog-corp/GT8Amniocentesis0111.pdf
11. Tran T,. Hepatitis B and pregnancy. Curr Hepat Rep 2009; 8: 154-156.
12. Giraudon I, Permalloo N, Nixon G, et al,. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006. Vaccine 2009; 27 (14): 2016-2022.